Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

Sparling speaks out about the motivation behind her heartfelt, yet humorous collection of essays. She discusses growing up with diabetes, 'mentalbetes,' the power of...
Maximize fun in the sun this summer with our skincare guide for people with diabetes. Here we share tips for how to protect your skin and stay healthy during the hottest...
Reduce heart failure risk with FDA-approved Inpefa (sotagliflozin). Inhibiting SGLT-2 and SGLT-1, it outshines other medications. Learn more about its effectiveness and...
In case you missed them, here are our top stories from May 2023. This month’s best stories cover a wide variety of topics like upcoming therapies, new research findings...
Oculis' OCS-01 eye drops show promising results in phase 3 trials for diabetic macular edema treatment. Uncover a potential revolution in non-invasive eye care solutions.
Explore key insights from the second annual Diabetes + Mental Health Virtual Conference. Learn about the intersection of these two critical health areas from experts,...
This clinical trial is currently recruiting – participants will be enrolled in one of two stress-intervention courses to measures changes in A1C, diabetes distress, and...
Explore how US Senator Jeanne Shaheen champions diabetes care at diaTribe's forum. Discover her insights on advancing time in range, lowering insulin costs, and...
Non-invasive glucose monitoring technology has been a dream of people with diabetes for years. Get the latest update on the research and development of these devices.
Explore the impact of hypoglycemia and technology in diabetes care. Watch the diaTribe panel for expert insights and personal experiences. Stay informed on managing...
Beta Bionics has received FDA clearance for its insulin-only iLet Bionic Pancreas, an automated insulin delivery system that eliminates the need for carbohydrate...
Explore the understated impact of hyperglycemia fears in diabetic children, the need for enhanced research, and strategies for safe diabetes management.
Farxiga (dapagliflozin), a SGLT-2 inhibitor, has officially been approved by the FDA to treat all types of heart failure, a common diabetes complication.
Learn how to increase access to diabetes tech for children with type 1 diabetes. Healthcare providers discuss how treatments and better access to resources can help...
Explore the challenges, insights, and triumphs of growing old with diabetes as long-term patients share their experiences and valuable advice.
With Mother’s Day 2023 coming up this Sunday, May 14, there’s no time to waste to find a special present for your special person with diabetes.
Glucomate can help people with type 1 diabetes identify trends in their glucose levels, view historical data, and make better decisions about managing their diabetes.
The FDA has cleared the Omnipod GO: a discreet, water-resistant insulin pod with up to 3 days of wear. Enjoy the freedom and convenience to manage your diabetes.
In case you missed them, below you’ll find our top stories from April 2023. This month’s best stories cover a wide variety of topics including medicare updates, upcoming...
The FDA recently cleared a new experimental drug for type 1 diabetes to begin a phase 2 clinical trial. If approved, the drug would be the first therapy to specifically...

Pages